eef2k inhibitor cefatrizine (Integrative Bioinformatics)
90
Structured Review
Integrative Bioinformatics
eef2k inhibitor cefatrizine
Eef2k Inhibitor Cefatrizine, supplied by Integrative Bioinformatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eef2k+inhibitor+cefatrizine/eef2k+inhibitor+cefatrizine/pm34162208-344-46-39
Average 90 stars, based on 1 article reviews
Eef2k Inhibitor Cefatrizine, supplied by Integrative Bioinformatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eef2k+inhibitor+cefatrizine/eef2k+inhibitor+cefatrizine/pm34162208-344-46-39
Average 90 stars, based on 1 article reviews
eef2k inhibitor cefatrizine - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Inhibiting Eukaryotic Elongation Factor 2 Kinase: An Update on Pharmacological Small-Molecule Compounds in Cancer. Article Snippet: Eukaryotic elongation factor 2 kinase (eEF2K), a member of the atypical protein kinase family of alpha-kinases, is well-known as a negative regulator of protein synthesis by phosphorylating eEF2.. Notably, eEF2K functions as a key regulator of several cellular processes, leading to tumorigenesis.. To date, some small-molecule compounds have been reported as potential eEF2K inhibitors in cancer drug discovery. Article Title: Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions. Article Snippet: Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, but an effective targeted therapy has not been wellestablished so far.. Considering the lack of effective targets, where do we go next in the current TNBC drug development?. A promising intervention for TNBC might lie in de novo small-molecule drugs that precisely target different molecular characteristics of TNBC. Activity Assay:Article Title: Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF-κB via the upregulation of CARD3 expression. Article Snippet: Yi Chen,†,∥ Guan Wang,†,∥ Haoyang Cai,‡,∥ Yang Sun, Liang Ouyang,† and Bo Liu*,† †State Key Laboratory of Biotherapy and Cancer Center and Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China ‡Center of Growth, Metabolism, and Aging, Key Laboratory of Bio-Resources and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610064, China State Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, China |